Changing attitudes to using interferon in pediatric patients with MPNs

Nicole Kucine, MD, MS, Weill Cornell Medicine, New York, NY, discusses the use of interferon in pediatric patients with myeloproliferative neoplasms (MPNs), commenting on whether clinicians have become more comfortable with prescribing this therapeutic option in the pediatric patient population. Dr Kucine expresses hope that prospective clinical trials will be initiated to investigate the use of ropeginterferon in young patients. This interview took place at the 1st Annual MPN Workshop of the Carolinas in Asheville, NC.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.